Nippon Chemiphar Of Japan, Ranbaxy Of India To Part Ways On Nihon
This article was originally published in PharmAsia News
Executive Summary
Japanese drug maker Nippon Chemiphar and India's Ranbaxy Laboratories are ending their nearly seven-year venture for selling generics in Japan. The two firms share equally in Nihon Pharmaceutical, which they created to market the generics made by Ranbaxy in India. Nippon Chemiphar, in the wake of fellow Japanese drug maker Daiicho Sankyo's purchase of Ranbaxy, now is negotiating with Ranbaxy to buy its 50 percent stake in Nihon. In addition to Ranbaxy's own review of its Japanese operations, the Nihon venture may not have been sufficiently profitable to satisfy Nippon Chemiphar. (Click here for more - a subscription may be required